Episode 1: The Sea Change
Why aren’t Americans embracing the most promising medications for treating over-drinking?
Alcohol consumption increased more during the COVID-19 pandemic than it had at any time in the past 50 years. Even though bars were closed for weeks on end and less people were out on the road doing their daily commuting, Americans were drinking so much that from 2020 through 2021 there were approximately 178,000 alcohol-related deaths - which is more deaths than from all drug overdoses combined, including opioids.
Yet, even as we return to 1960’s Mad Men era drinking habits - most Americans with a drinking problem never speak to their doctors about their drinking and less than 6% of them receive any form of treatment whatsoever. 12-step programs like Alcoholic Anonymous remain at the heart of a majority of American rehab programs, even though their “success rate” (which has historically been very hard to study) hovers around the single digits, while there are more effective medical options available.
Why?
On today’s episode, our friend Katie tells the story of her self-experimentation with the drug Naltrexone to combat her alcohol addiction and helps us grapple with why such medications are so rarely used to help problem drinkers in America.
Our thanks to our guests: Addiction psychiatrist Dr. Mark Willenbring and journalist Gabrielle Glazer.
Music in this episode from Cobey Bienart and Peter Lalish
Email your feedback, criticisms and story suggestions to hello@reflector.show
We will read all feedback and respond in a future episode.
Thank you to our sponsors. Visit them here to learn more:
FIRE
GROUND.NEWS
Other links:
Glazer’s 2015 article in The Atlantic
Andy’s 2015 public radio story on addiction treatments
Washington University’s National Survey Study
CDC’s study on recent alcohol-related deaths
2014 NYTimes stories on how Naltrexone and other drugs are rarely used
2021 NYTimes story on how things have not changed
Begin your Sinclair Method Youtube Rabbit Hole here
Great first episode! Subscribed and excited for more!
My journey here went:
Commentary Magazine - > I Might Be Wrong - > Blocked and Reported - > Smoke em if You Got em - > here.
Just to make the analyst's job easier!